Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol 3B Susceptibility to Plasmodium Vivax Infection and Malaria During Early Childhood

NCT00138489 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT00138489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00138489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol 3B Susceptibility to Plasmodium Vivax Infection and Malaria During Early Childhood
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Terminated
Start date
February 10, 2004
Completion date
Not reported
Enrollment
266
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plasmodium vivax malaria